📣 Help Shape the Future of UKRI's Gateway to Research (GtR)

We're improving UKRI's Gateway to Research and are seeking your input! If you would be interested in being interviewed about the improvements we're making and to have your say about how we can make GtR more user-friendly, impactful, and effective for the Research and Innovation community, please email gateway@ukri.org.

Rivaroxaban in Rheumatic Heart Disease-Associated Atrial Fibrillation. (2022)

First Author: Connolly SJ

Attributed to: L. Zuhlke, University of Cape Town: Etiological, intervention and outcome studies in African children, adolescents and young adults with heart disease funded by MRC

Abstract

No abstract provided

Bibliographic Information

Digital Object Identifier: http://dx.doi.org/10.1056/nejmoa2209051

PubMed Identifier: 36036525

Publication URI: http://europepmc.org/abstract/MED/36036525

Type: Journal Article/Review

Volume: 387

Parent Publication: The New England journal of medicine

Issue: 11

ISSN: 0028-4793